Dr. Gleicher Emphasizes the Importance of Early POA Screening

glamour_151102In an article on Glamour.com, Dr. Gleicher discussed the science behind diagnosing and treating premature ovarian aging. Dr. Gleicher emphasized the importance of catching POA early, and the possibility of getting risk-screened for this silent cause of infertility that affects 10% of all women. With early risk-screening for POA, young women can plan their reproductive life with the knowledge about their own body, and more specifically, about how their ovarian reserve is likely to change over time.

“This is the group of women our screening is addressing,” Dr. Gleicher is quoted in the article. “Fertility centers like ours see an exploding patient population in this category, and since they usually present to us very late—in their mid- to late 30s or 40s—there are limited options we can offer them. The best case is that they go into IVF quickly; the worst case is that they are unable to have biological children.”

The article coincided with the launch of the new POA screening offered as What’s My Fertility. CHR physicians and scientists have been working on the screening algorithm behind What’s My Fertility, and we are all very excited to have the Glamour cover the new screening tool.

Norbert Gleicher, MD, leads CHR’s clinical and research efforts as Medical Director and Chief Scientist. A world-renowned reproductive endocrinologist, Dr. Gleicher has published hundreds of peer-reviewed papers and lectured globally while keeping an active clinical career focused on ovarian aging, immunological issues and other difficult cases of infertility.